Prevalence and clinical significance of cathepsin G antibodies in systemic sclerosis
Objectives: To evaluate the prevalence and clinical significance of cathepsin G antibodies in patients affected with systemic sclerosis (SSc, scleroderma). Methods: 115 patients affected by SSc, 55 (47,8%) with diffuse scleroderma (dSSc) and 60 (52,2%) with limited scleroderma (lSSc), were tested fo...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2003-12-01
|
Series: | Reumatismo |
Online Access: | https://reumatismo.org/index.php/reuma/article/view/138 |